Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
Empresa
Empresa
Nuestra historia
Nuestro equipo
Carreras
Socios
News
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
Acceso
Asuntos médicos
Acceso de pacientes
Póngase en contacto con Asuntos Médicos
News
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
Recursos
Recursos
En las noticias
Comunicados de prensa
Recursos para pacientes
Preguntas frecuentes
News
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
Inversores
Inversores
Descripción general del inversor
Información financiera
Eventos
News
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
Agenus End of Year 2025 Stakeholder Briefing Webcast
Virtual Event
2025
Transmisión por Internet
Eventos archivados
¡Gracias! ¡Su presentación ha sido recibida!
¡Uy! Algo salió mal al enviar el formulario.
November 12, 2020 2:00 AM
Agenus and Dr. Steven O’Day Participate in B. Riley SITC 2020 Immuno-Oncology Virtual Panel
2020
October 29, 2020 9:30 AM
Agenus Third Quarter 2020 Financial Results
2020
Transmisión por Internet
October 26, 2020 1:00 PM
TIGIT Therapies Digital Summit
2020
September 21, 2020 3:18 AM
Agenus Discussion with Dr. David O'Malley and William Blair on ESMO Presentation of Balstilimab plus Zalifrelimab in Cervical Cancer
2020
Transmisión por Internet
September 18, 2020 10:00 AM
ESMO 2020 Presentation of Single-agent Anti-PD-1 Balstilimab or in Combination with Anti-CTLA-4 Zalifrelimab for Recurrent/Metastatic (R/M) Cervical Cancer (CC)